17 results
Summary of characteristics of Antianginal Drugs

DRUG CLASS, ADVERSE EFFECTS 
 AND DRUG 
INTERACTIONS 

#Antianginal #Medications #Cardiology
of Antianginal Drugs ... #Medications #Cardiology ... #Pharmacology # ... Management #Therapy ... #Table #Overview
Summary table of mechanism of action, side effect and contraindications of commonly used drugs for tuberculosis.
commonly used drugs ... for tuberculosis ... #pharmacology #medications ... #table #management ... #overview #tuberculosis
Warfarin color-coded tablets, initial dosing and INR targets

#pharmacology #overview #review #medications #drugs #cardiology #warfarin #management
INR targets #pharmacology ... #overview #review ... #medications #drugs ... #cardiology #warfarin ... #management
Brief Overview of Treatment Agents for COVID-19 - Version 2.01 4/11/2020

#Drugs #Medications #Treatment #COVID19 #Pharmacology #Table
Brief Overview of ... Treatment Agents ... 4/11/2020 #Drugs ... #COVID19 #Pharmacology ... #Table #Management
IDSA - Doses of Drugs for Treatment of Adults and Children with Multidrug-Resistant Tuberculosis
Step 1 Levofloxacin,
IDSA - Doses of Drugs ... for Treatment of ... #MDRTB #management ... #pharmacology # ... dosing #idsa #drugs
Migraine Treatment Overview

 • What is a Migraine?
 • Pathophysiology
 • Common Migraine Triggers
 • Diagnosis
Migraine Treatment ... Overview • ... Diagnosis • Non-Drug ... Treatment: • ... #management #pharmacology
IDSA - Clinical Strategy to Build an Individualized Treatment Regimen for Multi-Drug Resistant Tuberculosis (MDR-TB)
 •
Individualized Treatment ... Resistant Tuberculosis ... #MDRTB #management ... #Treatment #antimicrobials ... #regimens #pharmacology
Glaucoma is a condition that involves an increase in pressure inside the eye. It occurs when
pressure inside the eye ... drain out of the eye ... glaucoma and is the drug ... glaucoma #pharmacology ... #treatment #management
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
Tuberculosis Overview ... inhibitors • Injection drug ... Treatment: Active ... TB #Diagnosis #Management ... #Treatment #ActiveTB
Managing warfarin INR

Warfarin dosage must be individualized according to the patient's response to the drug, and
response to the drug ... #management #algorithm ... #pharmacology # ... treatment #medications ... #decisionaid #cardiology